Literature DB >> 18936316

Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.

Michael P Marks1, Jean-Marc Olivot, Stephanie Kemp, Maarten G Lansberg, Roland Bammer, Lawrence R Wechsler, Gregory W Albers, Vincent Thijs.   

Abstract

PURPOSE: To study magnetic resonance (MR) angiography findings in patients with acute stroke treated with intravenous tissue plasminogen activator (tPA) in relationship to perfusion- and diffusion-weighted imaging changes and clinical outcome.
MATERIALS AND METHODS: Patients treated with intravenous tPA 3-6 hours after stroke onset (with informed consent) were evaluated in a HIPAA-compliant multicenter prospective study approved by all institutional review boards. MR imaging and MR angiography studies were performed before and 3-6 hours after treatment. MR angiography studies that were technically adequate at both time points were evaluated for occlusion, decreased flow, any early recanalization, and degree of recanalization. These results were compared with favorable clinical response (an improvement in National Institutes of Health Stroke Scale score of >or=8 points at 30 days or a modified Rankin scale score of 0 or 1 at 30 days) in patients with and those without mismatch between perfusion- and diffusion-weighted imaging at baseline.
RESULTS: Seventy-four patients were enrolled in the initial investigation; pre- and posttreatment MR angiography studies were both technically adequate in 62 patients. MR angiography demonstrated occlusion or decreased flow in 46 patients. Patients with isolated middle cerebral artery (MCA) occlusion and early recanalization at MR angiography had higher rates of favorable clinical response than those with tandem internal carotid artery-MCA occlusion and early recanalization (P = .05). Any early recanalization was not associated with favorable clinical response, but degree of recanalization did correlate with favorable clinical response (P = .048). Favorable clinical response was more frequently seen in patients with mismatch between perfusion- and diffusion-weighted imaging findings at baseline who experienced early recanalization than in those who did not have early recanalization (odds ratio = 6.2; 95% confidence interval: 1.3, 30.2; P = .021). No relationship between early recanalization and favorable clinical response was seen in patients without mismatch.
CONCLUSION: Early recanalization seen at MR angiography before and after treatment coupled with diffusion- and perfusion-weighted imaging data may predict clinical outcome in patients with stroke treated with tPA 3-6 hours after symptom onset. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936316      PMCID: PMC2657860          DOI: 10.1148/radiol.2492071751

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors:  W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Refining the perfusion-diffusion mismatch hypothesis.

Authors:  K S Butcher; M Parsons; L MacGregor; P A Barber; J Chalk; C Bladin; C Levi; T Kimber; D Schultz; J Fink; B Tress; G Donnan; S Davis
Journal:  Stroke       Date:  2005-06       Impact factor: 7.914

3.  Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra.

Authors:  P A Barber; S M Davis; D G Darby; P M Desmond; R P Gerraty; Q Yang; D Jolley; G A Donnan; B M Tress
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

4.  Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.

Authors:  Maher Saqqur; Ken Uchino; Andrew M Demchuk; Carlos A Molina; Zsolt Garami; Sergio Calleja; Naveed Akhtar; Finton O Orouk; Abdul Salam; Ashfaq Shuaib; Andrei V Alexandrov
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.

Authors:  Ludy C Shih; Jeffrey L Saver; Jeffry R Alger; Sidney Starkman; Megan C Leary; Fernando Vinuela; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; J Pablo Villablanca; Paul M Vespa; Chelsea S Kidwell
Journal:  Stroke       Date:  2003-05-08       Impact factor: 7.914

7.  Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging.

Authors:  Vincent N Thijs; Diederik M Somford; Roland Bammer; Wim Robberecht; Michael E Moseley; Gregory W Albers
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.

Authors:  J Röther; P D Schellinger; A Gass; M Siebler; A Villringer; J B Fiebach; J Fiehler; O Jansen; T Kucinski; V Schoder; K Szabo; G J Junge-Hülsing; M Hennerici; H Zeumer; K Sartor; C Weiller; W Hacke
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

10.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  24 in total

Review 1.  Neuroimaging of cerebral ischemia and infarction.

Authors:  Carlos Leiva-Salinas; Max Wintermark; Chelsea S Kidwell
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Dramatically reducing imaging-to-recanalization time in acute ischemic stroke: making choices.

Authors:  M Goyal; M A Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-21       Impact factor: 3.825

3.  Imaging of acute ischemic stroke.

Authors:  Carlos Leiva-Salinas; Max Wintermark
Journal:  Neuroimaging Clin N Am       Date:  2010-11       Impact factor: 2.264

4.  Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.

Authors:  Xiang Fan; Zhanyang Yu; Jianxiang Liu; Ning Liu; Katherine A Hajjar; Karen L Furie; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

5.  Predictors of reperfusion in patients with acute ischemic stroke.

Authors:  A D Horsch; J W Dankbaar; J M Niesten; T van Seeters; I C van der Schaaf; Y van der Graaf; W P Th M Mali; B K Velthuis
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

Review 6.  Equipoise among recanalization strategies.

Authors:  T A Tomsick; P Khatri; T Jovin; B Demaerschalk; T Malisch; A Demchuk; M D Hill; E Jauch; J Spilker; J P Broderick
Journal:  Neurology       Date:  2010-03-30       Impact factor: 9.910

7.  Factors influencing clinically meaningful recanalization after IV-rtPA in acute ischemic stroke.

Authors:  A Murphy; S P Symons; J Hopyan; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

Review 8.  Acute stroke magnetic resonance imaging: current status and future perspective.

Authors:  Stephan P Kloska; Max Wintermark; Tobias Engelhorn; Jochen B Fiebach
Journal:  Neuroradiology       Date:  2009-12-05       Impact factor: 2.804

9.  Diffusion Kurtosis Imaging of Acute Infarction: Comparison with Routine Diffusion and Follow-up MR Imaging.

Authors:  Jianzhong Yin; Haizhen Sun; Zhiyun Wang; Hongyan Ni; Wen Shen; Phillip Zhe Sun
Journal:  Radiology       Date:  2018-03-20       Impact factor: 11.105

10.  Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.

Authors:  Li Zhang; Michael Chopp; Longfei Jia; Yisheng Cui; Mei Lu; Zheng Gang Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2009-07-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.